In a previous experiment it was reported that the intravenous administration of gadolinium chloride (GdCl,) to rats results in a discrete band of interstitial mineralization in the fundic glandular mucosa of the stomach. To investigate the time course for the development of this lesion and its relationship to plasma calcium and phosphate concentrations, 2 experiments were carried out in male Sprague-Dawley rats given a single intravenous dose of 0.07 mmol/kg GdCl,. Plasma calcium and phosphate concentrations approximately doubled between 30 min and 12 hr postdose but had regressed back to near normal values by 24 hr. However, there were no observable clinical signs in treated animals. Histologically, there was progressive mineralization of the lamina propria of the neck region of the fundic glands from 6 hr postdose, forming a distinctive mineral band by 12 hr postdose. At 7 and 14 days postdose the mineral deposits were accompanied by mucous cell hyperplasia, interstitial fibrosis, and a very sparse infiltration of inflammatory cells. By 56 days postdose only occasional mineral deposits remained. Transmission electron microscopy showed mineral first nucleated on collagen in the interstitium, but there was no evidence of cell necrosis. X-ray microanalysis showed that the interstitial mineral was composed of calcium and phosphate in the form of hydroxyapatite; gadolinium (Gd) was only very rarely identified. These findings are consistent with metastatic mineralization. The source, cause, and the exact nature of the excess plasma calcium and phosphate are unknown, and the possible significance of this effect for clinical use of Gd-containing chelates in nuclear magnetic resonance imaging requires further investigation.
INTRODUCTION
Chelates containing the lanthanide metal gadolinium (Gd) are used in diagnostic nuclear magnetic resonance imaging to provide enhanced contrast between healthy and diseased tissue. Preclinical safety and pharmacokinetic assessments have shown that Gd chelates have low toxicity and the likelihood of free ionized Gd reaching toxic concentrations in the body is considered to be low, because these chelates are not metabolized (4, 8, 13) .
However, there is a paucity of information regarding the toxicity and biodistribution of Gd salts in animals following intravenous administration with which to evaluate the toxicity of novel chelates. Although some specific effects of Gd salts have been investigated, for instance blockade of the mononuclear phagocytic system, hepatic necrosis, and anticoagulant activity (12, 16, 22, 26) , only recently were the effects on all organ systems investigated and reported by our group (22) . In that study the effects of a single intravenous administration of gadolinium chloride (GdCl3) in the rat were investigated 2 days and 14 days postadministration over a dosage range from 0.07 to 0.35 mmol/kg (22) . One striking and hitherto unreported feature was the presence of a band of interstitial mineralization around the neck region of the fundic glands of the stomach. The mineralization was most marked at the low-est dosage used and was followed by interstitial fibrosis and mucous cell hyperplasia. In contrast, the pylorus and nonglandular portions of the stomach were unaffected.
The aims of the present investigations were to describe the development of the morphologic changes in the stomach over time using histology, transmission electron microscopy (TEM), and x-ray microanalysis (XRMA) techniques. In addition, limited plasma chemistry parameters were measured to assess possible relationships of the morphologic effects to changes in calcium and phosphate.
MATERIALS AND METHODS
Animals and Husbandry. Male Sprague-Dawley rats (Charles River [UK] Ltd., Margate, Kent), [6] [7] [8] wk old at the start of the study, were housed in a room with temperature and relative humidity maintained at 21 ± 2°C and 55 ± 10% with a 12-hr light cycle. Rats had free access to mains water and a standard certified rodent maintenance diet (RMM diet, Special Diet Services, Manea, Cambs., UK).
Compound Formulation and Administration. Gadolinium(III) chloride hexahydrate (Aldrich Chemical Co., Gillingham, Dorset, UK) was dissolved in sterile 0.9% w/v sodium chloride at a concentration of 0.007 mmol/ml (equivalent to 1.85 mg/ml) and sterilized by filtration immediately prior to use. All rats received Gdci (treated) or sterile 0.9% sodium chloride (control) by intravenous injection via the lateral tail vein at a dosage volume of 10 ml/kg and an injection rate of 1-4 ml/min. In the first study animals were housed in standard plastic cages; in the second study they were placed in individual metabolism cages.
Clinical Observations. All rats were observed for changes in appearance and behavior at least twice daily for the duration of the study. Animals were weighed prior to randomization and on day 1 prior to dosing. Samples were analyzed for calcium, phosphate, and creatinine concentrations. However, due to technical problems, reliable values were not obtained for phosphate. At 48 hr postdose, all rats were sacrificed by an intraperitoneal injection of an overdose of 6% pentobarbitone and necropsied, and all stomachs were preserved for histopathology.
Assay Interference Study A preliminary in vitro study was carried out to examine potential interference by GdCl3 in the calcium and phosphate assays. A range of 0-1.75 mM GdCl3 was used, and interference was negligible over the plasma concentrations of GdC'3 expected for this study.
Anatomic Pathology
At necropsy the stomach of each animal was examined macroscopically, pinned out flat on cork board, and preserved in 10% neutral buffered formalin. A standard area of the fundic mucosa from the greater curvature was trimmed from each stomach, routinely processed, and embedded in paraffin wax. Four-micron-thick sections were stained as follows: hematoxylin and eosin (H&E) and Von Kossa (for mineral), Alizarin red (for mineral), and Picro-Mallory (for collagen) (2).
Transmission Electron Microscopy
Samples of the fundic mucosa from all animals in Experiment 1 and selected animals in Experiment 2 were fixed in modified Karnovsky's fixative in 0.1 M cacodylate buffer. Double fixation in osmium tetroxide was omitted to avoid spurious elemental peaks for x-ray microanalysis. After fixation, 3 samples/stomach were pro-cessed to resin blocks by a standard method. Light microscope sections (0.5 jjbm thick) were cut and stained with methylene blue/azure II and basic fuchsin. Thin sections (60-90 nm) were cut using glass knives on an ultramicrotome, collected on copper grids, and stained with uranyl acetate and lead citrate. Sections were examined on a Philips CM 10 electron microscope operating at 100 kV.
X-Ray Microanalysis
TEM sections (ca. 350 nm thick) were cut from 1 block/animal, mounted on copper grids, and examined unstained. Areas of interest were analyzed using an incident spot of 150-170 nm diameter, and spectra were acquired on an EDAX 9900 XRMA system attached to the transmission electron microscope. In addition, x-ray elemental distribution maps for calcium, phosphorous, gadolinium, magnesium, and arsenic (derived from cacodylate buffer used for EM processing) were acquired utilizing the EDAX 9900 XRMA system with an external beam and image deflection (EBID) unit.
Statistical Analysis
Analysis of variance techniques were used in the evaluation of clinical chemistry values in Experiment 2. If the group effect was significant in the model, contrasts were formed to compare the treated group to the control at each time point and to test for trend. Analyses were performed using the PROC GLM procedure in the SAS statistical package, version 6.09. A significance level of 0.05 was used.
RESULTS

Clinical Signs
There were no adverse clinical effects seen in any animal in either experiment.
Macroscopic Observations
In both experiments, stomachs from treated animals up to and including the 6 hr time point showed no changes compared to controls. From 12 hr to 14 days postdose, stomachs from all treated animals showed varying degrees of pallor of the fundic glandular mucosa. In addition, there was apparent thickening of the fundic glandular mucosa in animals 7 and 14 days postdose. In contrast, no changes were present in the pyloric antrum or nonglandular epithelium in any treated rat. No control stomach in either experiment showed any abnormality.
Clinical Chemistry
In both experiments, there were marked increases in plasma calcium and phosphate ( Fig. 1 ). In Experiment 1, values were approximately double the control level from the 30 min time point until 12 hr postdose (data not shown). In Experiment 2, where greater numbers of animals were used, approximate doubling of the concentrations were again observed 2, 4, 6, and 12 hr postdose with a smaller increase still present 24 hr postdose (Table  I) are summarised in Fig 1. In Experiment 2, a small but statistically significant decrease in plasma albumin was present between 4 hr and 2 days postdose. Plasma creatinine were always lower in the treated group than in controls, but only at 2 and 4 hr postdose was this statistically significant.
Adequate volumes of urine for analysis were collected from animals in the periods 0-2, 6-12, 12-24, and 24-48 hr. Calcium concentrations were not significantly different from controls at any time point, either when expressed in absolute terms or as a ratio to creatinine (Table   II) .
Histologic Observations
No abnormalities were detected in the stomach of the control rats or from GdCl,-treated rats up to 6 hr postdose. At with Von Kossa but not always with Alzarin red. Despite the extensive interstitial mineralization there was no evidence for any preceding cellular degeneration or necrosis of the epithelial or interstitial cells nor for any infiltration by inflammatory cells. Two cellular changes occurred after deposition. At 24 and 48 hr postdose, interstitial fibroblasts sometimes appeared abnormally basophilic, but necrotic cells were not identified. Some epithelial cells in the fundic glands also appeared to be abnormally vacuolated in paraffin sections, but only rarely were necrotic cells present. Most of this vacuolation in paraffin sections was artefactual as vacuolated epithelial cells were much less commonly identified in resin sections. In addition, increased numbers of epithelial cells undergoing cell division were identified at 24 and 48 hr postdose. and occasional foci of macrophages with the rare formation of giant cells (Figs. 4, 5 ). The increased rate of epithelial cell mitosis was still evident and had resulted in mucous cell hyperplasia. Consequently, at 7 and 14 days postdose the depth of the mucous cell layer was on average 4 times its normal thickness. However, the overall thickness of the mucosa only increased by up to 60% due to atrophy of the basal portions of the fundic glands. This overall increase in thickness was greater at day 7 than day 14. In the atrophic glands, both oxyntic and parietal cells were reduced in number and partially replaced by less differentiated cells with the gland lumina showing mild dilation.
By 56 days postdose, the extent of the lesions had diminished substantially; only scattered mineral deposits, small foci of interstitial fibrosis, and minimal multifocal mucous cell hyperplasia were present (Fig. 6 ).
Ultrastructual Observations
No changes were seen in GdCl~-treated rats until 6 hr postdose where focal, often circular, aggregations of needlelike crystals were observed in the lamina propria (Figs. 7, 8) . By 12 hr postdose, these had joined to form columns of mineral throughout the lamina propria of the neck region of the fundic glands. The density of mineralization continued to increase up to 48 hr postdose, so that the lamina propria was converted into electron-dense bands. The extent of mineralization was then little changed at days 7 and 14 but by day 56 only a few focal deposits remained. These mineral bands were formed by aggregations of needlelike crystals measuring ca. 150-300 nm by 50-100 nm. XRMA of these bands showed them to be composed of calcium and phosphorus with a Ca:P ratio of about 1.7:1. In contrast, Gd was never identified in these bands of mineral.
In addition to the mineral band, in the 2 animals from the 48 hr timepoint, a few mineral deposits of unusual shape were observed outside the mineral bands but within the interstitium. These deposits often had a cuboid shape and were not composed of fine needlelike crystals. With XRMA, these deposits gave a Ca:P ratio of approximately 1:1 with traces of magnesium.
The interstitial mineralization was not preceded by any evidence of degeneration or necrosis either in the epithelial cells or fibroblasts in the interstitium. However, alterations were observed in fibroblasts in some areas of toplasm and distortion in their shape. Deposits of mineral comprising calcium and phosphorus were frequently seen in phagolysosomes of fibroblasts. XRMA showed that such deposits were nearly always composed only of calcium and phosphorous. However hr and the other at 14 days postdose), occasional small deposits (<250 nm diameter) containing Gd as well as calcium and phosphorous were present in the interstitium and phagolysosomes of the fibroblasts.
At the early time points up to day 7, there was no evidence of necrosis of any cell type. Infrequently, corresponding to the histologic findings, epithelial cells showed cytoplasmic vacuolation and swelling of organelles, but there was no evidence of any generalized epithelial degeneration. In addition, there was no morphologic or XRMA evidence of mineral deposits in epithelial cells. At day 7 and day 14 time points only, 1 or 2 necrotic cells were occasionally found, and these had nucleation of mineral on cell remnants. Most of these cells appeared to be fibroblasts, but some could not be identified.
DISCUSSION
After a single intravenous administration of 0.07 mmol/kg GdCl, to rats, the stomach showed progressive mineralization of the lamina propria of the neck region of the fundic glands from 6 hr postdose, forming distinctive mineral bands at later time points. By TEM, mineral was first seen nucleating on collagen in the interstitium, and there was no evidence of cell necrosis preceding mineralization. XRMA showed that mineral bands were com- posed of calcium phosphate, in the form of hydroxyapatite, but no Gd. These findings are consistent with stomach mineralization occurring by metastatic mineralization and not on degenerate or necrotic cell remnants as in dystrophic mineralization (7) . Although very occasional necrotic cells were seen these appeared after the formation of mineral. There are many reports of metastatic mineralization occurring within otherwise normal tissues in the presence of hypercalcemia, and the gastric fundus is a site of preference for such mineralization, for example during hypervitaminosis D, in chronic renal failure, and in association with neoplasia (5-7). TEM and XRMA assessment revealed the progressive accumulation of calcium phosphate (hydroxyapatite), a type of mineral commonly found in metastatic mineralization of soft tissues (17) , in the lamina propria (interstitium). It seems likely that the predominance of calcium and phosphate in the mineral deposits reflects the clinical chemistry changes discussed below. Occasional foci of the mineral whitlockite, containing calcium, phosphorous, and trace amounts of magnesium, were found in 2 animals. Whitlockite has also been reported in pathologic mineralization in animals and humans (1, 17) , but its relationship to GdC%-administration is questionable because discrete foci of mineralization are occasionally found in the mucosa of control rats (10) . However, no ultrastructural or XRMA studies, with which to make comparisons, have been reported of such foci in control rats.
The nature of the mineralization in the stomach is different to that which occurs in other organs following a single administration of GdCl, at higher dosages of 0.14 and 0.35 mmol/kg (22) . XRMA identified widespread uptake of Gd, calcium, and phosphate complexes in the cells of the mononuclear phagocytic system, notably in the spleen and liver; a nonspecific entrapment of complexes in small blood vessels in the lungs and liver; and dystrophic mineralization in areas of hepatic and splenic necrosis (22) . Such a pattern is consistent with the formation of insoluble colloids in the plasma (discussed below) producing an &dquo;embolic shower&dquo; with uptake in splenic macrophages and hepatic Kupffer cells and subsequent necrosis in these organs (16) . Very similar findings have also been reported in the mouse following GdCl3 administration at dosages of up to 0.03 mmol/kg, where XRMA revealed gadolinium accumulation in hepatocytes, Kupffer cells, bile canaliculi and polymorphonuclear leucocytes in the liver, pulmonary and splenic macrophages, and mesangial cells in the kidney (26) .
In marked contrast, XRMA (both point analysis and digital x-ray mapping) failed to show the presence of Gd in the mineral bands in the stomach. Gd was only identified in 2 animals ( rat at the 6 hr and one at the day 14 time points), where small deposits (<250 nm diameter) containing calcium, phosphorus, and Gd were found in the interstitium and in phagolysosomes of fibroblasts. These deposits were very rare, and the presence of Gd might have provided a nucleation site for subsequent calcium and phosphorus deposition by the process described as &dquo;calcergy&dquo; (21) . Alternatively, Gd may have been trapped in a nonspecific manner secondary to deposition of calcium and phosphorus. Whatever the mechanism, the amount of Gd present in the gastric mineral was very small.
Hyperplasia of surface mucous cells occurred in conjunction with stomach mineralization, and this was reflected in the pallor and thickening of the glandular mucosa seen macroscopically. The extent of cellular necrosis appeared too minimal to be a significant factor in this response, although the effects in the mucosa between days 2 and 7 were not studied here. The hyperplasia with coexisting atrophy of the basal portion of the fundic glands was therefore interpreted as an adaptive response to mineralization of the mucosa because this combination occurs in a variety of situations where there is injury and/or inflammation in the gastric mucosa (3, 9) . A further interesting feature was the apparent regression of the hyperplasia and a decrease in mineralization after day 56. This finding needs to be confirmed with a greater number of animals, and additional time points would also be needed to determine whether mineral was lost by shedding of mucosa into the gastric lumen or resorption into the circulation. The presence of macrophages around some of the mineral deposits at 7 and 14 days postdose suggests that some, at least, is removed by phagocytosis.
The cause and nature of the transient hypercalcemia and hyperphosphatemia and the exact relationship between this and the gastric interstitial mineralization are unclear. Neither in the present study, nor in those recently reported by others using the same treatment regiment, were there any treatment-related clinical signs (18) . The marked hypercalcemia maintained at over 5 mmol/L for 6 hr might have been expected to induce some clinical effect because calcium levels are normally maintained within narrow limits in mammals (19) . Furthermore, after experimentally induced acute hypercalcemia following intraperitoneal administration of calcium chloride, most rats with serum concentrations in excess of 5 mmol/L showed signs of breathing difficulty, ataxia, motor incoordination, and aggression (25) . The likely reason for this difference is that ionized calcium has been shown to remain unchanged following intravenous administration of GdCl~ (18) . However, the exact form of the excess calcium and phosphate remains unknown. A significant amount of calcium is bound to plasma proteins, particularly albumin (5) ; but in contrast to the increase in calcium, there was a slight decrease in albumin in this experiment and no change in the study of Miller et al (18) . It is most likely that these electrolytes are bound with gadolinium in a colloid; similar colloids are formed after the intravenous injection of lead acetate where hypercalcemia and hyperphosphatemia are also induced (15, 20, 24) . Further evidence for the production of insoluble colloids in the serum comes from our previous study, in which widespread uptake of deposits composed of Gd, calcium, and phosphate in the cells of the mononuclear phagocytic system was described (22) .
The source for the excess calcium and phosphate is also unknown, although decreased renal clearance was not involved. Although only an incomplete picture of urinary electrolyte excretion was obtained in the present experiment, it is clear that calcium excretion was unchanged in the first 2 hr postdose, although serum calcium concentrations had approximately doubled. Furthermore, Miller et al also showed that the urinary concentrations of calcium and phosphate ions were not different from controls in the 24 hrs after intravenous administration of GdCl3 (18) . Miller et al also showed that the increases in plasma calcium and phosphate occur very quickly-within 5 min of intravenous administration of GdCl3 (18) . For such a quick effect to occur, it is most likely that these electrolytes are released from the &dquo;exchangeable calcium pool,&dquo; a normal homeostatic calcium source that comprises the bone surfaces and connective tissue where calcium is readily accessible for physiologic functions (23, 24) . With the intravenous injection of lead acetate, 2 mechanisms were proposed. Firstly, direct interaction of the metal ions with bone and connective tissue could occur with release of calcium and phosphate. Secondly, and more likely, the initial effect was the formation of insoluble colloids of lead, calcium, and phosphate causing transient hypocalcemia and hypophosphatemia and subsequent immediate release from the exchangeable calcium pool to maintain homeostasis of ionic calcium and phosphate (24) . There appears to be no role for parathyroid hormone or calcitonin in this effect: removal of these glands did not alter the ability of intravenously administered holmium chloride (another lanthanide chloride) to induce hypercalcemia and hyperphosphatemia (14) , and calcitonin secretion did not alter following the hypercalcemia induced by intravenously administered lead acetate (20) . In addition, in primary hyperparathyroidism the hypercalcemia is accompanied by normal or decreased plasma phosphate (5) , whereas GdCl~ like other metalic chlorides induced both hypercalcemia and hyperphosphatemia (14, 15, 24) .
The time course for the hypercalcemia and the hyperphosphatemia and the time course for gastric mineralization due to deposition of calcium and phosphate suggest a strong causal relationship. However, this is not a simple relationship, for lead acetate can produce the same serum effects but little gastric mineralization, whereas gastric mineralization also occurs following hypocalcemia induced by sodium pyrophosphate (Spencer, unpublished observations) . Furthermore, other groups have found no direct correlation between calcemia and phosphatemia caused by various metalic chlorides and their calcifying ability at the site of subcutaneous injection (21) . Recently, an additional histologic study of GdCl3-induced gastric mineralization in the rat was reported (11) , and the authors speculated that mineralization occurred adjacent to parietal cells, due to local pertubation of the function of these cells in conjunction with elevated plasma calcium concentrations.
